» Articles » PMID: 20109177

Mitochondrial Dysfunction and Mitophagy Activation in Blood Mononuclear Cells of Fibromyalgia Patients: Implications in the Pathogenesis of the Disease

Abstract

Introduction: Fibromyalgia is a chronic pain syndrome with unknown etiology. Recent studies have shown some evidence demonstrating that oxidative stress may have a role in the pathophysiology of fibromyalgia. However, it is still not clear whether oxidative stress is the cause or the effect of the abnormalities documented in fibromyalgia. Furthermore, the role of mitochondria in the redox imbalance reported in fibromyalgia also is controversial. We undertook this study to investigate the role of mitochondrial dysfunction, oxidative stress, and mitophagy in fibromyalgia.

Methods: We studied 20 patients (2 male, 18 female patients) from the database of the Sevillian Fibromyalgia Association and 10 healthy controls. We evaluated mitochondrial function in blood mononuclear cells from fibromyalgia patients measuring, coenzyme Q10 levels with high-performance liquid chromatography (HPLC), and mitochondrial membrane potential with flow cytometry. Oxidative stress was determined by measuring mitochondrial superoxide production with MitoSOX and lipid peroxidation in blood mononuclear cells and plasma from fibromyalgia patients. Autophagy activation was evaluated by quantifying the fluorescence intensity of LysoTracker Red staining of blood mononuclear cells. Mitophagy was confirmed by measuring citrate synthase activity and electron microscopy examination of blood mononuclear cells.

Results: We found reduced levels of coenzyme Q10, decreased mitochondrial membrane potential, increased levels of mitochondrial superoxide in blood mononuclear cells, and increased levels of lipid peroxidation in both blood mononuclear cells and plasma from fibromyalgia patients. Mitochondrial dysfunction was also associated with increased expression of autophagic genes and the elimination of dysfunctional mitochondria with mitophagy.

Conclusions: These findings may support the role of oxidative stress and mitophagy in the pathophysiology of fibromyalgia.

Citing Articles

Mitochondrial function in patients affected with fibromyalgia syndrome is impaired and correlates with disease severity.

Macchi C, Giachi A, Fichtner I, Pedretti S, Sarzi Puttini P, Sarzi-Puttini P Sci Rep. 2024; 14(1):30247.

PMID: 39632893 PMC: 11618515. DOI: 10.1038/s41598-024-81298-x.


Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients Monocyte/lymphocyte bioenergetic signatures post-TB treatment.

Cumming B, Addicott K, Maruri F, Pillay V, Asmal R, Moodley S Front Immunol. 2024; 15:1465448.

PMID: 39606220 PMC: 11599235. DOI: 10.3389/fimmu.2024.1465448.


Unraveling Shared Diagnostic Biomarkers of Fibromyalgia in Ankylosing Spondylitis: Evidence from Comprehensive Bioinformatic Analysis and Experimental Validation.

Bi W, Yang M, Mao R J Inflamm Res. 2024; 17:6395-6413.

PMID: 39310900 PMC: 11415292. DOI: 10.2147/JIR.S474984.


Identifying microRNAs Possibly Implicated in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Review.

Tsamou M, Kremers F, Samaritakis K, Roggen E Int J Mol Sci. 2024; 25(17).

PMID: 39273498 PMC: 11395538. DOI: 10.3390/ijms25179551.


Comparative Analysis of Psychophysiological Responses in Fibromyalgia Patients: Evaluating Neuromodulation Alone, Neuromodulation Combined with Virtual Reality, and Exercise Interventions.

Rubio-Zarapuz A, Apolo-Arenas M, Tomas-Carus P, Tornero-Aguilera J, Clemente-Suarez V, Parraca J Medicina (Kaunas). 2024; 60(3).

PMID: 38541130 PMC: 10971899. DOI: 10.3390/medicina60030404.


References
1.
DiMauro S . Mitochondrial myopathies. Curr Opin Rheumatol. 2006; 18(6):636-41. DOI: 10.1097/01.bor.0000245729.17759.f2. View

2.
Land J, Heales S, Duncan A, Hargreaves I . Some observations upon biochemical causes of ataxia and a new disease entity ubiquinone, CoQ10 deficiency. Neurochem Res. 2006; 32(4-5):837-43. DOI: 10.1007/s11064-006-9222-8. View

3.
Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, Yildizhan H . Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int. 2005; 26(7):598-603. DOI: 10.1007/s00296-005-0079-y. View

4.
Bazzichi L, Giannaccini G, Betti L, Fabbrini L, Schmid L, Palego L . ATP, calcium and magnesium levels in platelets of patients with primary fibromyalgia. Clin Biochem. 2008; 41(13):1084-90. DOI: 10.1016/j.clinbiochem.2008.06.012. View

5.
Pieczenik S, Neustadt J . Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol. 2007; 83(1):84-92. DOI: 10.1016/j.yexmp.2006.09.008. View